XML 52 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT INFORMATION (Tables)
 6 Months Ended
Jun. 30, 2017
Segment Reporting [Abstract]  
Schedule of segment revenues and profit
Segment revenues and profits for the three and six months ended June 30, 2017 and 2016 were as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(in millions)
2017
 
2016
 
2017
 
2016
Revenues:
 
 
 
 
 
 
 
Bausch + Lomb/International
$
1,241

 
$
1,277

 
$
2,391

 
$
2,423

Branded Rx
636

 
653

 
1,240

 
1,318

U.S. Diversified Products
356

 
490

 
711

 
1,051

 
2,233

 
2,420

 
4,342

 
4,792

 
 
 
 
 
 
 
 
Segment profits:
 
 
 
 
 
 
 
Bausch + Lomb/International
377

 
382

 
710

 
691

Branded Rx
341

 
337

 
667

 
594

U.S. Diversified Products
255

 
384

 
519

 
848

 
973

 
1,103

 
1,896

 
2,133

 
 
 
 
 
 
 
 
Corporate
(139
)
 
(136
)
 
(306
)
 
(340
)
Amortization of intangible assets
(623
)
 
(673
)
 
(1,258
)
 
(1,351
)
Asset impairments
(85
)
 
(230
)
 
(223
)
 
(246
)
Restructuring and integration costs
(18
)
 
(20
)
 
(36
)
 
(58
)
Acquired in-process research and development costs
(1
)
 
(2
)
 
(5
)
 
(3
)
Acquisition-related contingent consideration
49

 
(7
)
 
59

 
(9
)
Other income, net
19

 
46

 
259

 
21

Operating income
175

 
81

 
386

 
147

Interest income
3

 
2

 
6

 
3

Interest expense
(459
)
 
(472
)
 
(933
)
 
(899
)
Loss on extinguishment of debt
—

 
—

 
(64
)
 
—

Foreign exchange and other
39

 
12

 
68

 
6

Loss before recovery of income taxes
$
(242
)
 
$
(377
)
 
$
(537
)
 
$
(743
)
Schedule of total assets by segment
Total assets by segment were as follows:
(in millions)
June 30,
2017
 
December 31,
2016
Assets:
 
 
 
Bausch + Lomb/International
$
16,129

 
$
16,201

Branded Rx
19,407

 
21,143

U.S. Diversified Products
5,229

 
5,820

 
40,765

 
43,164

Corporate
968

 
365

Total assets
$
41,733

 
$
43,529